icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
An Integrated Safety Analysis of Daclatasvir + Sofosbuvir,
With or Without Ribavirin, in Patients With Chronic HCV Infection

 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Landis C,1 Nelson DR,2 Sulkowski M,3 Ruane P,4 Mills A,5 Poordad F,6 Wyles D,7 Bhore R,8 Ackerman P,9 Rana K,9 Swenson ES,9 Noviello S8
1University of Washington School of Medicine, Seattle, WA; 2University Of Florida, Dept. of Hepatology, Gainesville, FL; 3Johns Hopkins University, Baltimore, MD; 4Ruane Medical and Liver Health Institute, Los Angeles, CA; 5Anthony Mills MD, Inc; 6Texas Liver Institute, University of Texas Health Sciences, San Antonio, TX; 7University of California, San Diego, CA; 8Bristol-Myers Squibb, Princeton NJ; 9Bristol-Myers Squibb Research and Development, Wallingford, CT.

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif